Australia markets closed

Radiopharm Theranostics Limited (RAD.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0360-0.0040 (-10.00%)
At close: 03:59PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
Total revenue
292.359
292.359
8.831
Gross profit
292.359
292.359
8.831
Operating expenses
Research development
13,800
13,800
4,125
Selling general and administrative
13,021
13,021
10,848
Total operating expenses
34,800
34,800
19,925
Operating income or loss
-34,508
-34,508
-19,916
Interest expense
86.091
86.091
9,350
Total other income/expenses net
-124.048
-124.048
-1,028
Income before tax
-34,573
-34,573
-30,295
Income tax expense
38.005
38.005
44.397
Income from continuing operations
-34,611
-34,611
-30,339
Net income
-34,611
-34,611
-30,339
Net income available to common shareholders
-34,611
-34,611
-30,339
Basic EPS
-0.11
-0.11
-0.15
Diluted EPS
-0.11
-0.11
-0.15
Basic average shares
323,817
323,817
198,514
Diluted average shares
323,817
323,817
198,514